Celularity Inc — Director's Dealing 2025

Apr 15, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celularity Inc (CELU)
CIK: 0001752828
Period of Report: 2025-04-13

Reporting Person: Brigido Stephen (Pres., Functional Regeneration)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-04-13	Class A Common Stock	M	820	—	Acquired	9189	Direct
2025-04-13	Class A Common Stock	F	268	$1.64	Disposed	8921	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-04-13	Restricted Stock Units	$	M	820	Disposed		Class A Common Stock (820)	Direct

Footnotes

F1: Represents the conversion upon vesting of restricted stock units (RSUs) into Class A Common Stock. On April 13, 2022, the reporting person was granted 3,281 RSUs, 25% of which vested on April 13, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 28, 2022.

F2: This line reflects the tax withholding on the vesting of RSUs that vested on April 13, 2025.

F3: Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock.

F4: On April 13, 2022, the reporting person was granted 3,281 RSUs, 25% of which vested on April 13, 2025. The Class A Common Stock into which such vested RSUs converted on April 13, 2025 is reported in Table I on this Form 4.